Krystal Biotech Announces Participation in 2024 Cantor Global Healthcare Conference
Friday, 13 September 2024, 04:00
Krystal Biotech's Participation in Healthcare Conference
Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced its participation in the 2024 Cantor Global Healthcare Conference.
The conference is set to occur on date in location, gathering prominent experts and investors in the healthcare field.
Key Highlights of the Conference
- Networking Opportunities with industry leaders.
- Showcasing Innovations in biotechnology.
- Insights into market trends and research breakthroughs.
Krystal Biotech aims to leverage this platform to discuss recent developments and future directions in their product pipeline.
For more details, stay tuned!
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.